Lowe Brockenbrough & Co’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-750
| Closed | -$214K | – | 263 |
|
|
2023
Q2 | $214K | Sell |
750
-4
| -0.5% | -$1.14K | 0.02% | 264 |
|
|
2023
Q1 | $210K | Buy |
754
+4
| +0.5% | +$1.11K | 0.02% | 262 |
|
|
2022
Q4 | $208K | Hold |
750
| – | – | 0.02% | 258 |
|
|
2022
Q3 | $200K | Buy |
+750
| New | +$200K | 0.02% | 250 |
|
|
2021
Q4 | – | Sell |
-750
| Closed | -$212K | – | 256 |
|
|
2021
Q3 | $212K | Hold |
750
| – | – | 0.02% | 263 |
|
|
2021
Q2 | $260K | Hold |
750
| – | – | 0.02% | 209 |
|
|
2021
Q1 | $210K | Buy |
+750
| New | +$210K | 0.02% | 215 |
|
|
2020
Q4 | – | Sell |
-750
| Closed | -$213K | – | 211 |
|
|
2020
Q3 | $213K | Hold |
750
| – | – | 0.03% | 197 |
|
|
2020
Q2 | $201K | Hold |
750
| – | – | 0.03% | 202 |
|
|
2020
Q1 | $237K | Hold |
750
| – | – | 0.04% | 186 |
|
|
2019
Q4 | $223K | Sell |
750
-230
| -23% | -$68.4K | 0.03% | 205 |
|
|
2019
Q3 | $228K | Hold |
980
| – | – | 0.03% | 203 |
|
|
2019
Q2 | $229K | Hold |
980
| – | – | 0.03% | 200 |
|
|
2019
Q1 | $232K | Hold |
980
| – | – | 0.03% | 196 |
|
|
2018
Q4 | $295K | Sell |
980
-23
| -2% | -$6.92K | 0.05% | 173 |
|
|
2018
Q3 | $354K | Sell |
1,003
-18
| -2% | -$6.35K | 0.05% | 174 |
|
|
2018
Q2 | $296K | Hold |
1,021
| – | – | 0.04% | 180 |
|
|
2018
Q1 | $280K | Hold |
1,021
| – | – | 0.04% | 181 |
|
|
2017
Q4 | $325K | Hold |
1,021
| – | – | 0.05% | 175 |
|
|
2017
Q3 | $320K | Hold |
1,021
| – | – | 0.05% | 172 |
|
|
2017
Q2 | $277K | Hold |
1,021
| – | – | 0.04% | 176 |
|
|
2017
Q1 | $279K | Sell |
1,021
-50
| -5% | -$13.7K | 0.04% | 170 |
|
|
2016
Q4 | $304K | Hold |
1,071
| – | – | 0.05% | 168 |
|
|
2016
Q3 | $335K | Buy |
+1,071
| New | +$335K | 0.06% | 163 |
|